Literature DB >> 26417174

Two Draft FDA Guidance Documents Stir Controversy: Hospital and 503B Pharmacy Repackaging and Compounding Are at Issue.

Stephen Barlas.   

Abstract

The Food and Drug Administration hopes to close gaps in laws related to repackaging of pharmaceuticals or biologics by hospital pharmacies and bulk compounding facilities.

Year:  2015        PMID： 26417174      PMCID： PMC4571843     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  1 in total

1.  Challenging Food and Drug Administration interpretations of the Federal Food, Drug, and Cosmetic Act.

Authors:  Richard M Cooper
Journal:  Food Drug Law J       Date:  2003       Impact factor: 0.619
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.